PDLLA vs PLLA
This page places verifiable specifications side by side. It does not rank materials, score them, or recommend one over another.
Comparison
What is the difference between PDLLA and PLLA in aesthetic use?
Both are polylactic acid polyesters used as dermal biostimulatory materials and they share the same repeat unit. They differ in stereochemistry: PDLLA is racemic and therefore amorphous, while PLLA is built from a single stereoisomer and is semi-crystalline. Their regulatory identities also diverge in the United States, where an injectable PLLA implant holds FDA premarket approval while a standalone PDLLA equivalent could not be established from public sources.
| Aspect | PDLLA (Poly-D,L-lactic acid) | PLLA (Poly-L-lactic acid) | Basis |
|---|---|---|---|
| Stereochemistry | Racemic — contains both D and L lactic acid units | Single stereoisomer — L units only | — |
| Crystallinity | Amorphous; the racemic chain does not crystallise | Semi-crystalline | — |
| Breakdown route | Hydrolysis to lactic acid monomers | Hydrolysis to lactic acid monomers; the literature associates crystallinity with a slower rate, though this is not measured head to head | — |
| Presentation described in the literature | Amorphous microspheres | Semi-crystalline microparticles; injectable forms described as lyophilised powder reconstituted before use | — |
| Regulatory identity — Korea | Medical device, tissue-repair biomaterial route | Medical device, tissue-repair biomaterial route | Legal text |
| Regulatory identity — European Union | Medical device under MDR Annex XVI, Section 3 | Medical device under MDR Annex XVI, Section 3 | Legal text |
| Regulatory identity — United States | Not established from public sources | Device pathway; an injectable implant holds premarket approval PMA P030050 | Legal text |
| Randomised trial cited on this site | PMID 39178357 — evaluator-blinded multicentre comparison | PMID 38206151 — injectable implant versus no treatment for cheek wrinkles | — |
Why the stereochemistry matters
Lactic acid exists as two mirror-image forms. A chain built only from the L form can pack into crystalline regions; a chain built from a random mix of D and L cannot, and stays amorphous. This is the whole of the chemical difference between the two materials, and everything else follows from it or from how a given manufacturer processes the polymer.
What is not established
The step that is often asserted — that the crystallinity difference produces a specific difference in how long each material persists in tissue — is not supported here by a head-to-head study. The literature reports the association, and the polymer chemistry makes it plausible, but a controlled comparison within one protocol is a different kind of evidence and this page does not have one to cite.
Where they genuinely diverge on record
The clearest documented difference is regulatory rather than physical. In the United States an injectable PLLA implant carries premarket approval on the device pathway, with the generic name “implant, dermal, for aesthetic use”. For a standalone injectable PDLLA product, no equivalent record was found in the agency database. In Korea and the European Union the two are handled the same way.
Limitations & open questions
No study cited here compares the two materials head to head within one protocol. The differences in this table are drawn from separate studies and from polymer chemistry, so the breakdown row in particular describes an association reported in the literature rather than a measured comparison. Particle specifications are not standardised between manufacturers, so a figure reported for one product does not describe the stereoisomer class as a whole.